"Engineered Polymerases And Methods Of Using The Same" in Patent Application Approval Process (USPTO 20240052325).

A patent application has been filed for engineered polymerases and their use in DNA synthesis. The current methods of DNA synthesis can produce unclear results due to nonspecific products. The invention addresses this issue by using fusion proteins that include a target DNA polymerase and an intein, which inhibits the polymerase activity. This invention has potential applications in various fields, including COVID-19 testing. For more information, please refer to the full patent application. [Extracted from the article]